MedTrace Logo

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

NCT03824002 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2019-01-31

No results posted yet for this study

Summary

The study aims to evaluate arterial stiffness and endothelial function indexes and their relationship with clinic and laboratory varible in a group of diabetic patients in treatment with dulaglutide

Conditions

Interventions

DRUG

Dulaglutide

Diabetes therapy with dulaglutide and various combinations of insulin, metformin, glinides

DRUG

Aspart insulin

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Glargine

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Metformin

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Repaglinide

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-10-01
Completion
2018-04-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824002 on ClinicalTrials.gov